CD70 antibody‐drug conjugate: A potential novel therapeutic agent for ovarian cancer

This study aimed to investigate the cytotoxicity of a cluster of differentiation 70 antibody‐drug conjugate (CD70‐ADC) against ovarian cancer in in vitro and in vivo xenograft models. CD70 expression was assessed in clinical samples by immunohistochemical analysis. Western blotting and fluorescence‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiomi, Mayu, Matsuzaki, Shinya, Serada, Satoshi, Matsuo, Koji, Mizuta‐Odani, Chihiro, Jitsumori, Mariko, Nakae, Ruriko, Matsuzaki, Satoko, Nakagawa, Satoshi, Hiramatsu, Kosuke, Miyoshi, Ai, Kobayashi, Eiji, Kimura, Toshihiro, Ueda, Yutaka, Yoshino, Kiyoshi, Naka, Tetsuji, Kimura, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409415/
https://www.ncbi.nlm.nih.gov/pubmed/34117815
http://dx.doi.org/10.1111/cas.15027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409415/
https://www.ncbi.nlm.nih.gov/pubmed/34117815
http://dx.doi.org/10.1111/cas.15027

Ejemplares similares